Lancet Psychiatry最新文献

筛选
英文 中文
Treatment paradigms for treatment-resistant schizophrenia. 耐药性精神分裂症的治疗范例。
IF 30.8 1区 医学
Lancet Psychiatry Pub Date : 2024-07-01 DOI: 10.1016/S2215-0366(24)00173-1
Carol Lim, Abigail L Donovan
{"title":"Treatment paradigms for treatment-resistant schizophrenia.","authors":"Carol Lim, Abigail L Donovan","doi":"10.1016/S2215-0366(24)00173-1","DOIUrl":"10.1016/S2215-0366(24)00173-1","url":null,"abstract":"","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":null,"pages":null},"PeriodicalIF":30.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141328004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Target trial emulation in psychiatry: a call for more rigorous observational analyses. 精神病学中的目标试验模拟:呼吁进行更严格的观察分析。
IF 30.8 1区 医学
Lancet Psychiatry Pub Date : 2024-07-01 Epub Date: 2024-05-02 DOI: 10.1016/S2215-0366(24)00104-4
Alejandro G Szmulewicz
{"title":"Target trial emulation in psychiatry: a call for more rigorous observational analyses.","authors":"Alejandro G Szmulewicz","doi":"10.1016/S2215-0366(24)00104-4","DOIUrl":"10.1016/S2215-0366(24)00104-4","url":null,"abstract":"","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":null,"pages":null},"PeriodicalIF":30.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140871103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive performance in functional seizures compared with epilepsy and healthy controls: a systematic review and meta analysis. 功能性癫痫发作与癫痫和健康对照组的认知表现比较:系统综述和元分析。
IF 30.8 1区 医学
Lancet Psychiatry Pub Date : 2024-07-01 DOI: 10.1016/S2215-0366(24)00132-9
Ryan Van Patten, Tara A Austin, Erica Cotton, Lawrence Chan, John A Bellone, Kristen Mordecai, Hamada Altalib, Stephen Correia, Elizabeth W Twamley, Richard N Jones, Kelsey Sawyer, W Curt LaFrance
{"title":"Cognitive performance in functional seizures compared with epilepsy and healthy controls: a systematic review and meta analysis.","authors":"Ryan Van Patten, Tara A Austin, Erica Cotton, Lawrence Chan, John A Bellone, Kristen Mordecai, Hamada Altalib, Stephen Correia, Elizabeth W Twamley, Richard N Jones, Kelsey Sawyer, W Curt LaFrance","doi":"10.1016/S2215-0366(24)00132-9","DOIUrl":"10.1016/S2215-0366(24)00132-9","url":null,"abstract":"<p><strong>Background: </strong>Cognition is a core component of functional seizures, but the literature on cognition in this disorder has been heterogeneous, with no clear unifying profile emerging from individual studies. The aim of this study was to do a systematic review and meta-analysis of cognitive performance in adults with functional seizures compared with epilepsy (including left temporal lobe epilepsy) and compared with healthy non-seizure cohorts.</p><p><strong>Methods: </strong>In this systematic review and meta-analysis, starting Feb 6, 2023, replicated and updated on Oct 31, 2023, a medical librarian searched MEDLINE, Embase, PsycINFO, and Web of Science. Inclusion criteria were full reports documenting raw or standardised cognitive test data in adults with functional seizures compared with adults with epilepsy, prospectively recruited healthy comparisons, or published norms. Grey literature was retained and there were no language or date restrictions. We excluded studies only reporting on mixed functional seizures and epilepsy, or mixed functional neurological samples, with no pure functional seizures group. Risk of bias was evaluated using a modified version of the Newcastle-Ottawa Scale. People with lived experiences were not involved in the design or execution of this study. This study is registered as CRD42023392385 in PROSPERO.</p><p><strong>Findings: </strong>Of 3834 records initially identified, 84 articles were retained, including 8654 participants (functional seizures 4193, epilepsy 3638, and healthy comparisons 823). Mean age was 36 years (SD 12) for functional seizures, 36 years (12) for epilepsy, and 34 years (10) for healthy comparisons, and the proportion of women per group was 72% (range 18-100) for functional seizures, 59% (range 15-100) for epilepsy, and 69% (range 34-100) for healthy comparisons. Data on race or ethnicity were rarely reported in the individual studies. Risk of bias was moderate. Cognitive performance was better in people with functional seizures than those with epilepsy (Hedges' g=0·17 [95% CI 0·10-0·25)], p<0·0001), with moderate-to-high heterogeneity (Q[56]=128·91, p=0·0001, I<sup>2</sup>=57%). The functional seizures group performed better than the epilepsy group on global cognition and intelligence quotient (g=0·15 [0·02-0·28], p=0·022) and language (g=0·28 [0·14-0·43], p=0·0001), but not other cognitive domains. A larger effect was noted in language tests when comparing functional seizures with left temporal lobe epilepsy (k=5; g=0·51 [0·10 to 0·91], p=0·015). The functional seizures group underperformed relative to healthy comparisons (g=-0·61 [-0·78 to -0·44], p<0·0001), with significant differences in all cognitive domains. Meta regressions examining effects of multiple covariates on global cognition were not significant.</p><p><strong>Interpretation: </strong>Patients with functional seizures have widespread cognitive impairments that are likely to be clinically meaningful on the basis o","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":null,"pages":null},"PeriodicalIF":30.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141327998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discontinuation symptoms of antidepressants. 抗抑郁药的停药症状。
IF 30.8 1区 医学
Lancet Psychiatry Pub Date : 2024-07-01 Epub Date: 2024-06-05 DOI: 10.1016/S2215-0366(24)00174-3
Glyn Lewis, Gemma Lewis
{"title":"Discontinuation symptoms of antidepressants.","authors":"Glyn Lewis, Gemma Lewis","doi":"10.1016/S2215-0366(24)00174-3","DOIUrl":"10.1016/S2215-0366(24)00174-3","url":null,"abstract":"","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":null,"pages":null},"PeriodicalIF":30.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
De-implementation to reduce coercive practices in mental health care. 取消强制措施,减少心理健康护理中的强制做法。
IF 30.8 1区 医学
Lancet Psychiatry Pub Date : 2024-07-01 DOI: 10.1016/S2215-0366(24)00144-5
Sophie Sergerie-Richard, Marie-Hélène Goulet, Alexandre Dumais, Catherine Hinse, Guillaume Fontaine
{"title":"De-implementation to reduce coercive practices in mental health care.","authors":"Sophie Sergerie-Richard, Marie-Hélène Goulet, Alexandre Dumais, Catherine Hinse, Guillaume Fontaine","doi":"10.1016/S2215-0366(24)00144-5","DOIUrl":"10.1016/S2215-0366(24)00144-5","url":null,"abstract":"","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":null,"pages":null},"PeriodicalIF":30.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141327999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive coding and phenomenological approaches of delusions: convergence and differences - Authors' reply. 妄想症的预测编码和现象学方法:趋同与差异--作者回复。
IF 30.8 1区 医学
Lancet Psychiatry Pub Date : 2024-07-01 Epub Date: 2024-05-02 DOI: 10.1016/S2215-0366(24)00141-X
Jessica Niamh Harding, Noham Wolpe, Stefan Peter Brugger, Victor Navarro, Christoph Teufel, Paul Charles Fletcher
{"title":"Predictive coding and phenomenological approaches of delusions: convergence and differences - Authors' reply.","authors":"Jessica Niamh Harding, Noham Wolpe, Stefan Peter Brugger, Victor Navarro, Christoph Teufel, Paul Charles Fletcher","doi":"10.1016/S2215-0366(24)00141-X","DOIUrl":"10.1016/S2215-0366(24)00141-X","url":null,"abstract":"","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":null,"pages":null},"PeriodicalIF":30.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140852532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Worldwide incidence of suicides in prison: a systematic review with meta-regression analyses. 全球监狱中自杀事件的发生率:系统回顾与元回归分析。
IF 30.8 1区 医学
Lancet Psychiatry Pub Date : 2024-07-01 Epub Date: 2024-05-29 DOI: 10.1016/S2215-0366(24)00134-2
Adrian P Mundt, Pablo A Cifuentes-Gramajo, Gergő Baranyi, Seena Fazel
{"title":"Worldwide incidence of suicides in prison: a systematic review with meta-regression analyses.","authors":"Adrian P Mundt, Pablo A Cifuentes-Gramajo, Gergő Baranyi, Seena Fazel","doi":"10.1016/S2215-0366(24)00134-2","DOIUrl":"10.1016/S2215-0366(24)00134-2","url":null,"abstract":"<p><strong>Background: </strong>Suicide is a leading cause of death during imprisonment. This systematic review aimed to synthesise available evidence of prison suicide incidence worldwide.</p><p><strong>Methods: </strong>We systematically searched the scientific literature, data repositories, and prison system reports, supplemented by correspondence with prison administrations. We included reports on people living in prison but excluded studies in preselected groups (by age or offence type). Absolute numbers and incidence rates of suicide mortality per 100 000 person-years by sex and country were extracted from 2000 to 2021. IQRs were used to describe the suicide incidence in different world regions. Incidence rate ratios comparing suicides of people living in prison with age-standardised general populations were calculated. We conducted meta-regression analyses on national-level and prison-level factors to examine heterogeneity. The study protocol was pre-registered with PROSPERO, CRD42021296819.</p><p><strong>Findings: </strong>We included three scientific studies, 124 official reports, and 11 datasets from email correspondence. Between 2000 and 2021, there were 29 711 reported suicides during 91·2 million person-years of imprisonment in 82 jurisdictions worldwide (sex-specific data available for 13 289 individuals: 12 544 [94·4%] male and 745 [5·6%] female individuals). There were large variations between countries, with most studies reporting suicide rates in the range of 24-89 per 100 000 person-years in both sexes (22-86 in male individuals and 25-107 in female individuals). In meta-regression analyses, Europe (vs other regions), high-income countries (vs low-income and middle-income countries), and countries with lower incarceration rates (vs those with higher incarceration rates) had higher suicide rates. Incidence rate ratios between people who are incarcerated and age-standardised general populations in the same jurisdictions were typically in the range of 1·9-6·0 in male and 10·4-32·4 in female individuals.</p><p><strong>Interpretation: </strong>Prison services worldwide, and particularly in Europe, should prioritise suicide prevention. Assessment and management of suicide risk in female individuals living in prison need particular attention due to excess mortality relative to community-based populations. Interpretation of synthesised data needs to be done with caution due to high heterogeneity between jurisdictions.</p><p><strong>Funding: </strong>Agencia Nacional de Investigación y Desarrollo, Economic and Social Research Council, and Wellcome Trust.</p>","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":null,"pages":null},"PeriodicalIF":30.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141187183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishing a research agenda for the study and assessment of opioid withdrawal. 制定研究和评估阿片类药物戒断的研究议程。
IF 30.8 1区 医学
Lancet Psychiatry Pub Date : 2024-07-01 Epub Date: 2024-03-20 DOI: 10.1016/S2215-0366(24)00068-3
Kelly E Dunn, Eric C Strain
{"title":"Establishing a research agenda for the study and assessment of opioid withdrawal.","authors":"Kelly E Dunn, Eric C Strain","doi":"10.1016/S2215-0366(24)00068-3","DOIUrl":"10.1016/S2215-0366(24)00068-3","url":null,"abstract":"<p><p>The opioid crisis is an international public health concern. Treatments for opioid use disorder centre largely on the management of opioid withdrawal, an aversive collection of signs and symptoms that contribute to opioid use disorder. Whereas in the past 50 years more than 90 medications have been developed for depression, only five medications have been developed for opioid use disorder during this period. We posit that underinvestment has occurred in part due to an underdeveloped understanding of opioid withdrawal syndrome. This Personal View summarises substantial gaps in our understanding of opioid withdrawal that are likely to continue to limit major advancements in its treatment. There is no firm consensus in the field as to how withdrawal should be precisely defined; 10-550 symptoms of withdrawal can be measured on 18 scales. The imprecise understanding of withdrawal is likely to result in overestimating or underestimating the severity of an individual's withdrawal syndrome or potential therapeutic effects of different candidate medications. The severity of the opioid crisis is not remitting, and an international research agenda for the study and assessment of opioid withdrawal is necessary to support transformational changes in withdrawal management and treatment of opioid use disorder. Nine actionable targets are delineated here: develop a consensus definition of opioid withdrawal; understand withdrawal symptomatology after exposure to different opioids (particularly fentanyl); understand precipitated opioid withdrawal; understand how co-exposure of other drugs (eg, xylazine and stimulants) influences withdrawal expression; examine individual variation in withdrawal phenotypes; precisely characterise the protracted withdrawal syndrome; identify biomarkers of opioid withdrawal severity; identify predictors of opioid withdrawal severity; and understand which symptoms are most closely associated with treatment attrition or relapse. The US Food and Drug Administration recently established a formal indication for opioid withdrawal that has invigorated interest in drug development for opioid withdrawal management. Action is now needed to support these interests and help industry identify new classes of medications so that real change can be achieved for people with opioid use disorder.</p>","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":null,"pages":null},"PeriodicalIF":30.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140194867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive dysfunction in functional seizures: a neurologist's perspective. 功能性癫痫发作的认知功能障碍:神经学家的视角。
IF 30.8 1区 医学
Lancet Psychiatry Pub Date : 2024-07-01 DOI: 10.1016/S2215-0366(24)00177-9
Ingrid Hoeritzauer
{"title":"Cognitive dysfunction in functional seizures: a neurologist's perspective.","authors":"Ingrid Hoeritzauer","doi":"10.1016/S2215-0366(24)00177-9","DOIUrl":"10.1016/S2215-0366(24)00177-9","url":null,"abstract":"","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":null,"pages":null},"PeriodicalIF":30.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141327997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
School-based interventions to support mental health in adolescents: what works BESST? 支持青少年心理健康的校本干预措施:BESST 的哪些措施有效?
IF 64.3 1区 医学
Lancet Psychiatry Pub Date : 2024-07-01 Epub Date: 2024-05-14 DOI: 10.1016/S2215-0366(24)00139-1
Deborah M Caldwell
{"title":"School-based interventions to support mental health in adolescents: what works BESST?","authors":"Deborah M Caldwell","doi":"10.1016/S2215-0366(24)00139-1","DOIUrl":"10.1016/S2215-0366(24)00139-1","url":null,"abstract":"","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":null,"pages":null},"PeriodicalIF":64.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140960391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信